Skip to main content
padlock icon - secure page this page is secure
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 17, Number 2, February 2017

Articles

Free Content Graphical Abstracts
pp. i-iii(3)

Favourites:
ADD

Free Content Meet Our Editorial Board Member
pp. 99-99(1)
Author: Cho, William

Favourites:
ADD

Anticancer Potential and Molecular Targets of Pristimerin: A Mini- Review
pp. 100-108(9)
Authors: A. Yousef, Bashir; M. Hassan, Hozeifa; Zhang, Lu-Yong; Jiang, Zhen-Zhou

Favourites:
ADD

Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors
pp. 109-121(13)
Authors: Federico, Alessandro; Zappavigna, Silvia; Dallio, Marcello; Misso, Gabriella; Merlino, Francesco; Loguercio, Carmela; Novellino, Ettore; Grieco, Paolo; Caraglia, Michele

Favourites:
ADD

Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
pp. 122-136(15)
Authors: Wang, Nan; Wu, Yue; Bian, Jinlei; Qian, Xue; Lin, Hongzhi; Sun, Haopeng; You, Qidong; Zhang, Xiaojin

Favourites:
ADD

Targeting Key Metabolic Enzymes Involved in Lipid and Protein Biosyntheses for Breast Anticancer Therapies
pp. 158-168(11)
Authors: Guerram, Mounia; Mejda Hamdi, Aida; Zhang, Lu-Yong; Jiang, Zhenzhou

Favourites:
ADD

Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region
pp. 169-176(8)
Authors: Liang, Yuanxin; Zeng, Jinwu; Jelicks, Linda; Ma, Shengwei; Liu, Jing; Mei, Jingsong; Perez-Soler, Roman; Zou, Yiyu

Favourites:
ADD

CYR61 Confers the Sensitivity to Aromatase Inhibitor Letrozole in ER Positive Breast Carcinoma
pp. 191-197(7)
Authors: Jia, Xiaoqing; Liu, Guangyu; Cheng, Jingyi; Shen, Zhenzhou; Shao, Zhimin

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more